Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod

Background. Natalizumab- (NTZ-) associated progressive multifocal leukoencephalopathy (PML) is a severe and often disabling infectious central nervous system disease that can become evident in multiple sclerosis (MS) patients after NTZ discontinuation. Recently, novel diagnostic biomarkers for the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinnecker, Tim, Othman, Jalal, Kühl, Marc, Metz, Imke, Niendorf, Thoralf, Kunkel, Annett, Paul, Friedemann, Wuerfel, Jens, Faiss, Juergen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138460/
https://www.ncbi.nlm.nih.gov/pubmed/27994897
http://dx.doi.org/10.1155/2016/5876798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5138460/
https://www.ncbi.nlm.nih.gov/pubmed/27994897
http://dx.doi.org/10.1155/2016/5876798

Ejemplares similares